Literature DB >> 25516456

Paraneoplastic pyoderma gangrenosum with posttransplant lymphoproliferative disorder.

Urvi Shah1, Athena Kritharis, Andrew M Evens.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25516456      PMCID： PMC4831911          DOI： 10.1007/s00277-014-2277-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  6 in total

1.  Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Authors:  J-E Gottenberg; L Guillevin; O Lambotte; B Combe; Y Allanore; A Cantagrel; C Larroche; M Soubrier; L Bouillet; M Dougados; O Fain; D Farge; X Kyndt; O Lortholary; C Masson; B Moura; P Remy; T Thomas; D Wendling; J-M Anaya; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2004-11-18       Impact factor: 19.103

2.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Authors:  Ralf Trappe; Stephan Oertel; Veronique Leblond; Peter Mollee; Monica Sender; Petra Reinke; Ruth Neuhaus; Hans Lehmkuhl; Heinz August Horst; Gilles Salles; Franck Morschhauser; Arnaud Jaccard; Thierry Lamy; Malte Leithäuser; Heiner Zimmermann; Ioannis Anagnostopoulos; Martine Raphael; Hanno Riess; Sylvain Choquet
Journal:  Lancet Oncol       Date:  2011-12-13       Impact factor: 41.316

Review 3.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

4.  Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Authors:  Andrew M Evens; Kevin A David; Irene Helenowski; Beverly Nelson; Dixon Kaufman; Sheetal M Kircher; Alla Gimelfarb; Elise Hattersley; Lauren A Mauro; Borko Jovanovic; Amy Chadburn; Patrick Stiff; Jane N Winter; Jayesh Mehta; Koen Van Besien; Stephanie Gregory; Leo I Gordon; Jamile M Shammo; Scott E Smith; Sonali M Smith
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

5.  A case of granulomatosis with polyangiitis and pyoderma gangrenosum successfully treated with infliximab and rituximab.

Authors:  Salim Donmez; Omer N Pamuk; Mustafa Gedik; Recep A K; Gulay Bulut
Journal:  Int J Rheum Dis       Date:  2014-01-27       Impact factor: 2.454

6.  Paraneoplastic pyoderma gangrenosum.

Authors:  C M Duguid; S O'Loughlin; B Otridge; F C Powell
Journal:  Australas J Dermatol       Date:  1993       Impact factor: 2.875
  6 in total
  1 in total

Review 1.  [Acute lymphoblastic leukemia complicated with pyoderma gangrenosum: a case report and literatures review].

Authors:  X Shi; Z G Cui; F Hou; H Xu; H Wang; Z Su; H G Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.